Is Neil Woodford taking a huge risk with his Income Focus Fund portfolio?

Paul Summers take a look at which companies have made it into the star fund manager’s new dividend-focused fund.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Yesterday afternoon, star fund manager Neil Woodford revealed which stocks had been selected for his new Income Focus Fund. While some names are no surprise, others are likely to raise more than a few eyebrows. Let’s take a look at a sample of those which have made the grade and ask: has the UK’s most trusted professional investor’s need to offer sizeable returns forced him to take on too much risk?

A few old favourites 

Taking up over 7% of the portfolio, pharmaceuticals giant Astrazeneca remains a firm favourite with the former Invesco man. No doubt Woodford will be buoyed by the positive outcome from recent trials of its Infinzi lung cancer drug.

Legal & General and tobacco giant Imperial Brands take up the second and third slots in the portfolio. With respective yields of just under 6% and 4.6% for the current year, that’s to be expected. Further down, 5.7%-yielding Lloyds Bank also makes an appearance.

While not a part of his hugely popular Equity Income fund, it’s easy to see why Woodford has also opted to include Aviva as a significant holding in the Income Focus portfolio. Under the stewardship of CEO Mark Wilson, the £22bn cap insurer has been hiking dividends at a rapid pace over the last few years.

More risk, less reward?

Other selections may be more controversial, however. Indeed, thanks to the need to generate substantial dividends, it seems Woodford has become more contrarian than ever before.

Take the inclusion of utility behemoth SSE. Yesterday’s announcement that dividend cover would be “within, but towards the bottom range of around 1.2 to 1.4 times ” wasn’t particularly reassuring. Theresa May’s proposal to introduce a price cap on standard variable tariffs if elected is hardly good news either.

Clothing retailer Next, is another curious selection, particularly as the FTSE 100 giant’s high street stores are continuing to struggle as more consumers migrate online. Representing 2% of the fund portfolio, Woodford clearly believes these concerns have been overdone.

Debt-ridden breakdown specialist AA, and troubled outsourcer Capita also make the cut, despite the latter experiencing a truly awful 2016.

Elsewhere, some may consider the inclusion of housebuilders within the portfolio as risky considering that the full impact of Brexit is still unknown. Taylor Wimpey, Barratt Developments, Crest Nicholson and Bovis Homes all make an appearance. According to Woodford however, “people are too downbeat about the UK economy,” leaving these stocks trading on “depressed valuations.” Let’s hope he’s right.

Safety in diversity?

To generate superior results from investing — be it in the form of capital gains or dividends — means doing things that many investors wouldn’t, in the hope it doesn’t backfire. To achieve the 5% yield targeted by the fund, that’s exactly what Neil Woodford is required to do. Time will tell as to whether his optimistic outlook on certain constituents was justified.

That said, one of the attractions of investing in funds such as Income Focus is the instant diversification on offer. A less concentrated basket of shares like this might prevent investors from making life-changing gains immediately, but it also offers a degree of security should one, two or several be forced to revise their dividend policies.

So, while I don’t necessarily share Woodford’s confidence on every selection, the wide spread of companies from different markets and industries should allow those invested to sleep at night.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca, Imperial Brands, and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Prediction: these FTSE 100 stocks could be among 2025’s big winners

Picking the coming year's FTSE 100 winners isn't an easy task, but we're all thinking about it at this time…

Read more »

Investing Articles

This UK dividend share is currently yielding 8.1%!

Our writer’s been looking at a FTSE 250 dividend share that -- due to its impressive 8%+ yield -- is…

Read more »

Investing Articles

If an investor put £10,000 in Aviva shares, how much income would they get?

Aviva shares have had a solid run, and the FTSE 100 insurer has paid investors bags of dividends too. How…

Read more »

Investing Articles

Here’s why I’m still holding out for a Rolls-Royce share price dip

The Rolls-Royce share price shows no sign of falling yet, but I'm still hoping it's one I can buy on…

Read more »

Investing Articles

Greggs shares became 23% cheaper this week! Is it time for me to take advantage?

On the day the baker released its latest trading update, the price of Greggs shares tanked 15.8%. But could this…

Read more »

Investing Articles

Down 33% in 2024 — can the UK’s 2 worst blue-chips smash the stock market this year?

Harvey Jones takes a look at the two worst-performing shares on the FTSE 100 over the last 12 months. Could…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Are National Grid shares all they’re cracked up to be?

Investors seem to love National Grid shares but Harvey Jones wonders if they’re making a clear-headed assessment of the risks…

Read more »

Investing For Beginners

Here’s what the crazy moves in the bond market could mean for UK shares

Jon Smith explains what rising UK Government bond yields signify for investors and talks about what could happen for UK…

Read more »